Stock screener

OGEN

Conviction 0HealthcareScan · Thu, Jun 25, 2026
Bearish marubozu
OGEN$0.5865-0.26%
ResistanceSupportVol 14
63 bars
Vol MA14 41.1K
Mar 25Apr 13Apr 30May 18Jun 5Jun 24
ORAGENICS INCPharmaceutical Preparationswww.oragenics.com
Price0.5865
Change-0.26%
Gap+2.04%
Rel volume0.57×
Avg volume53.52K
Avg $ vol32.03K
SMA 200.6000
SMA 500.6114
SMA 2000.8714
Price vs 50-4.07%
Price vs 200-32.69%
MA stackbearish
50/200 cross
Supertrenddown · 0.6940
RSI (14)46
MACD hist-0.00
MACD crossbear · 3d
Stoch %K / %D46 / 43
ADX (14)17
+DI / −DI13 / 18
RSI divergence
MACD divergenceBearish
ATR %+6.28%
ADR %5.88%
52w high4.05
52w low0.5038
From 52w high-85.52%
Above 52w low+16.42%
New 52w highNo
SqueezeOn · 27d
Bollinger width11.10%
%B0.30
Donchian pos38.81%
Donchian high0.6450
Donchian low0.5494
AVWAP (52w high)1.17
vs AVWAP high-50.06%
AVWAP (52w low)0.6126
vs AVWAP low-4.26%
OBV trendDown
Chaikin MF (20)-0.19
Today vs 20d0.57×
Avg vol (14d)41.09K
Avg vol (20d)53.52K
Avg $ vol (20d)32.03K
Market cap2.65M
RS 3m (vs SPY)-22.03%
RS 6m (vs SPY)-40.92%
RS line new highNo
Trend template0/8
Technical rank24.2
1 week-3.95%
1 month-1.76%
3 months-9.77%
6 months-33.19%
1 year-83.53%
YTD-29.76%
P/E-0.27
P/B0.43
P/S70.28
P/FCF-0.28
EPS-4.56
Div yield
ROE-159.22%
ROA-131.41%
Debt/Eq
Current4.17
EV/EBITDA0.37
Gross margin0.00%
Net margin
Rev growth0.00%
EPS growth6.86%
Price target
Target upside
Analyst rating
Institutional
Ent. value-3.46M
Revenue7.47K
Net income-2.2M
Gross profit0
Free cash flow-9.37M
IndustryPharmaceutical Preparations
ExchangeNYSE
Shares out4.51M
Employees3
ListedThu, Jul 3, 2003
Free float3.3M
Float %76.2%
Short interest708.93K
Days to cover16.7d
Short volume89.6%
Squeeze score85 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank24.2 / 100
Group rank
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish marubozu
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OGEN

All disclosures →
No recent disclosed trades by Congress in OGEN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OGEN

No recent insider (Form 4) filings in OGEN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in OGEN

EDGAR →

No recent SEC filings on file for OGEN.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.